Expanded Access Policy

Clinical trials, and the subsequent approval of a therapy, can provide long-term access to new therapies. Patients interested in an investigational product which has not yet been approved are encouraged to speak with their doctor to be evaluated for possible participation in Savara’s future clinical trials. Please find information on our ongoing clinical trials by searching for Savara or NCT04544293 at www.clinicaltrials.gov.

Currently, Savara is not offering expanded access in the United States. Our policy on expanded access will be reviewed on a regular basis and as more information and clinical data on the safety and efficacy of molgramostim become available. We encourage you to stay informed regarding any developments by visiting the Expanded Access Navigator.

For additional information, physicians can contact info@savarapharma.com. Someone will respond within approximately 5 business days.